BIOREGENX, INC. 10-Q filing
Filed 2026-05-20 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001683168-26-004178
- Form type
- 10-Q
- CIK
- 0001593184
- Primary document
- https://www.sec.gov/Archives/edgar/data/1593184/000168316826004178/bioregenx_i10q-33126.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOREGENX, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $426,175 | - | - |
| Cost Of Revenue | $77,887 | - | - |
| Gross Profit | $348,288 | - | - |
| Operating Income | $-49,764 | - | - |
| Net Income | $-26,415 | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Total Assets | $337,070 | - | - |
| Total Liabilities | $4.9M | - | - |
| Shareholders Equity | $-4.5M | - | - |
| Operating Cash Flow | $26,629 | - | - |